Dishman Pharmaceuticals

2010 January 27

by Srinivas

Dishman Pharmaceuticals and Chemicals Ltd has informed about commissioning of its World-class High Containment API facility for manufacture of a range of Oncology APIs and other related high potency products at its Bavla complex, near Ahmedabad. This facility has been set up primarily by the Technical Team of Dishman’s Swiss Subsidiary namely Carbogen Amcis AG.

Comments are closed for this entry.

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 India License

Vigilance Theme by Jestro

DISCLAIMER : Stock trading involves high risk and one can lose Substantial amount of money.The recommendations made herein Do not constitute an offer to sell or solicitation to buy any of the Securities mentioned. No representations can be made that recommendations contained herein will be profitable or they will Not result in losses. Readers using the information contained herein are solely responsible for their actions. The information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on technical analysis only.

News about Indian Stock Markets

Dishman Pharmaceuticals

Recent Posts

Categories

Archives

Search

Authors

What I'm Doing...